0001437749-18-004830.txt : 20180316
0001437749-18-004830.hdr.sgml : 20180316
20180316104321
ACCESSION NUMBER: 0001437749-18-004830
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruck Claudine
CENTRAL INDEX KEY: 0001733680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 18694583
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017-3552
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-03-15
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001733680
Bruck Claudine
4995 BRADENTON AVE., SUITE 240
DUBLIN
OH
43017
1
Common Stock
2018-03-15
4
A
0
50000
0.001
A
50000
D
Stock Option
0.75
2018-03-15
4
A
0
50000
0.001
A
2019-03-15
2028-03-15
Common Stock
50000
50000
D
Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant.
/s/ Jed A. Latkin for Claudine Bruck, by power of attorney
2018-03-16